Literature DB >> 24327529

Analysis of patients with γ-heavy chain disease by the heavy/light chain and free light chain assays.

Erin Kaleta, Robert Kyle, Raynell Clark, Jerry Katzmann.   

Abstract

BACKGROUND: The objective of this study was to evaluate the performance of the heavy/light chain and free light chain immunoassays in patients with heavy chain disease, and to assess the ability of the heavy/light chain assay to measure and confirm the abnormal, truncated heavy chain.
METHODS: Frozen serum samples from 15 γ-heavy chain disease patients were tested for IgGκ, IgGλ, total IgG, free light chains, and M-spike concentrations.
RESULTS: The (Gκ+Gλ)/IgGtotal ratio for these 15 patients ranged from 0.02 to 0.80. The 10 patients with IgG concentrations above 1 g/dL all had ratios below 0.3 indicating that a substantial portion of IgG was not quantitated by the Gκ and Gλ reagents. The average M-spike was 1.61 g/dL and the average calculated abnormal γ-chain concentration was 2.94 g/dL. Additionally, free light chain analysis revealed the presence of monoclonal free κ light chain in three of the 15 patients.
CONCLUSIONS: This study demonstrates utility of a nephelometric assay to identify truncated immunoglobulin heavy chains in γ-HCD and that 20% of these patients also have monoclonal free light chain.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24327529     DOI: 10.1515/cclm-2013-0714

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  2 in total

1.  Identification of gamma heavy chain disease using MALDI-TOF mass spectrometry.

Authors:  Katie L Thoren; Marion Eveillard; Patrick Chan; Sital Doddi; Sun Cho; Kazunori Murata
Journal:  Clin Biochem       Date:  2019-12-26       Impact factor: 3.281

2.  Two Cases of γ-Heavy Chain Disease and a Review of the Literature.

Authors:  I Ramasamy; Z Rudzki
Journal:  Case Rep Hematol       Date:  2018-08-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.